Aspira Womens Health (FRA:CUL) Price-to-Tangible-Book : (As of May. 25, 2024)

View and export this data going back to . Start your Free Trial

What is Aspira Womens Health Price-to-Tangible-Book?

As of today (2024-05-25), Aspira Womens Health's share price is €2.02. Aspira Womens Health's Tangible Book per Share of Mar. 2024 for the quarter that ended in Mar. 2024 was €-0.10. Hence, Aspira Womens Health's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Aspira Womens Health's Price-to-Tangible-Book or its related term are showing as below:

During the past 13 years, Aspira Womens Health's highest Price to Tangible Book Ratio was 72.25. The lowest was 3.17. And the median was 7.80.

FRA:CUL's Price-to-Tangible-Book is not ranked ^*
in the Medical Diagnostics & Research industry.
Industry Median: 2.47
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Aspira Womens Health's share price is €2.02. Aspira Womens Health's Book Value per Sharefor the quarter that ended in Mar. 2024 was €-0.10. Hence, Aspira Womens Health's P/B Ratio of today is .

Aspira Womens Health Price-to-Tangible-Book Historical Data

The historical data trend for Aspira Womens Health's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aspira Womens Health Price-to-Tangible-Book Chart

Aspira Womens Health Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Get a 7-Day Free Trial

8.84

64.98

6.47

5.71

Aspira Womens Health Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Price-to-Tangible-Book	Get a 7-Day Free Trial															49.03	-	-	-	-

Competitive Comparison of Aspira Womens Health's Price-to-Tangible-Book

For the Diagnostics & Research subindustry, Aspira Womens Health's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aspira Womens Health's Price-to-Tangible-Book Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Aspira Womens Health's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Aspira Womens Health's Price-to-Tangible-Book falls into.

Aspira Womens Health Price-to-Tangible-Book Calculation

Aspira Womens Health's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Mar. 2024 )
	=	2.02	/	-0.102
	=

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Aspira Womens Health Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Aspira Womens Health's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Aspira Womens Health (FRA:CUL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Aspira Womens Health Inc (FRA:CUL) » Definitions » Price-to-Tangible-Book

Comparable Companies

DRIO OCX ENZ BIAF PRE TTOO XGN DMTK SLDX MYNZ TMO DHR IQV XSWX:LONN IDXX A MTD ICLR ILMN WAT

Traded in Other Exchanges

AWH:USA

Address

12117 Bee Caves Road, Suite 100, Building 3, Austin, TX, USA, 78738

Website

https://www.aspirawh.com

Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. The Company markets and sells, 1) Ova1, a blood test intended as an aid to assess the likelihood of malignancy in women with an ovarian adnexal mass for which surgery is planned when the physician's independent clinical and radiological evaluation does not indicate malignancy; (2) Overa, a second-generation biomarker reflex intended to maintain Ova1's high sensitivity while improving specificity; (3) Ova1Plus, a reflex offering which uses Ova1 as the primary test and Overa as a confirmation for Ova1 intermediate range results; and (4) OvaWatch, a lab-developed blood test intended to assist in the initial clinical assessment of malignancy risk in all women with an adnexal mass.

Aspira Womens Health (FRA:CUL) Headlines

No Headlines